Indeed, CD4+ T cells are enriched in lesions of MS patients and EAE studies further revealed two pathogenic T helper subsets important for disease: interferon gamma (IFN-γ)-producing type 1 T helper (TH1) cells and IL-17 producing type 17 T helper (TH17) cells (36). Here, IFNG is linked to myeloid sarcoma.